Cedars-Sinai has been awarded $11.99 million by California’s stem cell agency to launch a clinical trial testing a potential gene and stem cell therapy for amyotrophic lateral sclerosis (ALS).
[Cedars-Sinai]
Sorry, but the selected Zotpress account can't be found.
